were significantly increased in the isolated CAE group than the control group with normal coronary arteries (p¼0.002). This result shows that there is vascular involvement at the renal glomerular level in CAE. Additionally, similar to previous studies, it can be considered that CAE is not a localized disease and is a generalized pathology which affects the entire vascular bed. It can also be postulated that increased levels of microalbumin has a significant relationship with increased cardiovascular morbidity and mortality in CAE patients. To decrease the level of microalbuminuria with any therapy can aid in reducing devastating cardiovascular end points.
Background and Aim: Coronary artery ectasia (CAE) causes chest pain in the absence of obstructive coronary artery stenosis. Mechanisms of coronary ectasia development includes atherosclerosis by 50%, congenital causes by 20-30%, inflammation or connective tissue diseases by10-20%. We aimed to investigate aortic stiffness (AS), aortic distensibility (AD) and aortic propagation velocity (APV) in coronary ectasia patients with either critical or non-critical coronary artery disease. Material-Methods: The patients who underwent coronary angiography with anginal complaints at our institution were included in the study. 49 coronary ectasia patients with critical coronary artery stenosis of >50%, 49 coronary ectasia patients with non critical coronary artery stenosis of <50% and 47 patients with normal coronary arteries were included in the study. Age, gender, weight, height, and biochemical parameters were noted and echocardiographic AS, AD, APV measurements were made. Results: There were significant differences among three groups with regard to AS, AD, APV (p<0.05) ( Figure 1 ). APV was significantly correlated with AS, AD, coronary ectasia score (p<0.05) ( Figure 2) . Conclusions: APV might be an echocardiographic marker of coronary ectasia both in the presence and absence of critical coronary artery disease.
OP-029
Association of Pregnancy-Associated Plasma Protein A (PAPP-A), Coronary Calcification Score and Carotid Intima-Media Thickness Aim: Atherosclerosis is the most common cause of mortality and morbidity in the world. Estimation of the existence of atherosclerotic coronary artery disease before clinically presentation is very important for cardiovascular risk evaluation. Coronary calcium score (CCS), carotid intima-media thickness (CIMT) and pregnancy associated plasma protein-A (PAPP-A) are predictors for the development of atherosclerosis. In this study it was aimed to investigate the relationship between CCS, CIMT and PAPP-A for diagnosing atherosclerosis earlier. Albumin/creatinine ratio (mg/mg) 0,036AE0,040 0,018AE0,013 0,002
Patients
Method: Ninety-nine patient having multi-detected computerized tomography (MDCT) between December 2011 and December 2012 were included in study. All patients were selected from individuals who underwent MDCT in our hospital with a suspicion of coronary artery disease. The levels of the CCS, CIMT and PAPP of the patients were calculated. Demographic properties, whether or not having risk factors of atherosclerosis and the laboratory parameters of the study patients have been recorded.
Results: 25 women (%25,3), 74 men (%74,7) were admitted to our study. The mean age was 52,8AE13,1. In forty-three patients (%43,4), atherosclerotic plague were detected in carotid artery. The presence of carotid artery plague (CAP) were associated the existence of coronary artery disease (CAD) (p<0,001). The occurrence of CAP were more frequent in patients with diabetes mellitus and hypertension compared without them (consequently p<0,001; p¼0,003). PAPP-A, CCS and CIMT values were also higher in patients with diabetes and hypertension. A significant correlation between PAPP-A and CCS (p<0,001), moderate correlation between CCS and CIMT were observed (p<0,001). Grading the CAD of patients according to MDCT, the optimal cut-off point of PAPP-A in detecting CAD was 2,35 ng/ml with 94,3% sensitivity and 68,3% specificity the optimal cut-off point of right and left CIMT in detecting CAD was 0,6 mm with 75% sensitivity and 87,3% specificity for right CIMT and with 75% sensitivity and 79,4% specificity for left CIMT.
Conclusion: Our study showed that levels of CIMT, CCS, PAPP-A were associated in patient with subclinical and obvious CAD. The values of PAPP-A, CCS, and CIMT have been found higher in patients who has traditional atherosclerotic risk factors. Accordingly, we concluded that it is proper to use the parameters of PAPP-A, CCS and CIMT in investigating the subclinical atherosclerosis and in guiding treatment. However in order to have more precise cut-off points, larger studies must be carried on. Aim: Restenosis is an important limitation for coronary stenting. The cause of stent restenosis is neointimal hyperplasia developed from smooth muscle and matrix. We aimed to investigate the association between urotensin II (U-II) and restenosis after coronary stenting which causes endothelial and muscle proliferation and accumulation of collagen. Methods: Total 153 patient was enrolled to the study who meet criteria for angiographic indication underwent coronary artery angiography. All patient have history undergone for coronary stent implantation 3 to 9 months ago. Restenosis is identified as more than %50 narrowing inside the stent. Restenosis was observed in 73 and remaining of 80 patients revealed no critical lesion in stent on angiographic evaluation. Plasma level measurement of U-II was performed in all subjects. Results: There was statistically significant association between restenosis and U-II level (p¼0.03). High level of U-II level independently was linked with coronary stent restenosis. In subgroup analysis we also observed following multivariate statistical significance: negative correlation was found between restenosis and renin-angiotensinsystem (RAS) blocker usage (p¼0.040) and right coronary artery (RCA) lesions interventions (p¼0.018). Conclusion: This study revealed for the first time that there is a significant relationship between coronary stent restenosis and plasma U-II values. According to the our study findings high plasma U-II level might be accepted as a risk factors for stent restenosis. Restenosis is less developed after RCA interventions and taking drug of RAS blockages. Our study findings need to be confirmed in further studies.
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Relationship between Coronary Stent Restenosis and Plasma Urotensin II Level
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